Introduction
PP2A is one of the major protein serine/threonine phosphatases in the cell. It plays a role in several cellular processes, including metabolism, transcription, RNA splicing, translation, cell cycle progression, morphogenesis, signal transduction, development, and transformation (Mumby and Walter, 1993; Wera and Hemmings, 1995) . However, the mechanisms regulating activity and function of this enzyme in vivo are not well de®ned.
The predominant form of PP2A in cells is a heterotrimer consisting of three subunits. Two of them, the 36 kDa catalytic C subunit and the 63 kDa regulatory A subunit (PR65) form the core enzyme, and the B subunit binds the core enzyme to form the holoenzyme. The A and C subunits both exist as two isoforms (a and b), which are closely related, whereas the B subunit is variable, and its multiple isoforms belong to at least three unrelated gene families, B/B55/ PR55, B'/B56/PR61, and B''/PR72/PR130 (Kamibayashi et al., 1994; McCright and Virshup, 1995; Csortos et al., 1996) . The cellular B subunits can also be replaced by viral proteins, such as the SV40 small t antigen and the polyomavirus small and middle T antigens (Mumby, 1995) . Although the three B subunit gene families do not share sequence homologies, they all bind overlapping regions on the PP2A-A subunit that include some amino acids required for binding of all subunits, and few amino acids which are speci®cally involved in binding of one or two types of B subunits (Ruediger et al., 1999) .
The various cellular PP2A B subunits target the PP2A holoenzyme to dierent substrates and dictate its subcellular localization. For example, the B/B55 subunit enhances the ability of PP2A to dephosphorylate substrates of cdc2 kinase (Sola et al., 1991; Agostinis et al., 1992; Ferrigno et al., 1993) , and loss of the B/B55/PR55 gene is associated with defects in cytokinesis in both yeast and Drosophila (Healy et al., 1991; Mayer-Jaekel et al., 1993) . Thus, the B/B55 subunit dictates a role for PP2A in mitosis. The B'/B56/PR61 subunit was recently shown to interact with the Wnt-b catenin signal transduction pathway and inhibit it (Seeling et al., 1999) . PR59, a B'' family member, interacts with the retinoblastomarelated p107 protein, but not with the Rb protein.
Elevated expression of PR59 results in dephosphorylation of p107, but not of pRb, indicating that distinct regulatory B subunits target PP2A to speci®c substrates (Voorhoeve et al., 1999) . The B/B55 subunit was reported to target PP2A to microtubules (Sontag et al., 1995) , and to vimentin (Turowski et al., 1999) , whereas the various members of the B'/B56 family were shown to be present in the cytoplasm or in the nucleus (McCright et al., 1996) , and at focal adhesions (Ito et al., 2000) . The core heterodimer was reported to represent at least one-third of the total PP2A in some cells (Kremmer et al., 1997) , and to associate with neuro®laments (Saito et al., 1995) . Complementation analysis in yeast has con®rmed that the dierent B subunits perform non-redundant functions (Zhao et al., 1997) .
Reversible covalent modi®cations of the PP2A catalytic subunit (PP2A-C) were shown to regulate activity and subunit composition of the enzyme. The C-terminus of PP2A-C, which contains sites for phosphorylation and carboxymethylation seems to be important for interaction with regulatory B subunits (Ogris et al., 1997; Bryant et al., 1999) .
A growing body of evidence indicates that regulation of PP2A involves not only the phosphatase subunits, but also its association with additional cellular and viral proteins in multiprotein complexes. For example, PP2A has been shown to interact with b 2 -adrenergic receptor (Pitcher et al., 1995) , casein kinase 2a (Heriche et al., 1997) , HOX 11 (Kawabe et al., 1997) , tau (Sontag et al., 1996) , translation termination eukaryotic release factor 1 (Andjelkovic et al., 1996) , a4 protein (Murata et al., 1997) , caspase 3 (Santoro et al., 1998) , Bcl-2 (Deng et al., 1998) , neuro®lament proteins (Strack et al., 1997) , and several other proteins. Recently, it was shown that PP2A exists also as part of signaling complexes together with CaMKIV (Westphal et al., 1998) , and with p70-S6 kinase or PAK1 and PAK3 . It seems that the assembly of protein-kinase-PP2A signaling modules plays an important role in control of various intracellular signaling cascades.
Adenovirus E4orf4 protein is a multifunctional protein. Our work, as well as work from other laboratories, has shown that the E4orf4 protein down regulates expression of genes that have been activated by E1A and cAMP (MuÈ ller et al., 1992; Kleinberger and Shenk, 1993) , induces hypophosphorylation of various viral and cellular proteins (MuÈ ller et al., 1992; Kanopka et al., 1998) , regulates alternative splicing of adenovirus mRNAs (Kanopka et al., 1998) , and induces p53-independent apoptosis in transformed cells Marcellus et al., 1998; Shtrichman and Kleinberger, 1998) . We have previously shown that E4orf4 interacts with the PP2A holoenzyme through a direct association with the a isoform of the B subunit (Ba) (Kleinberger and Shenk, 1993) . We have recently shown that the interaction with PP2A complexes that include the Ba subunit is required for induction of apoptosis by E4orf4 (Shtrichman et al., 1999) . The presence of an active PP2A also contributes to other functions performed by the E4orf4 protein, including down regulation of transcription (Kleinberger and Shenk, 1993; Bondesson et al., 1996; Whalen et al., 1997) , and control of alternative splicing (Kanopka et al., 1998) .
We report here that the adenovirus E4orf4 protein interacts not only with the PP2A-Ba subunit, but also with several members of the PP2A-B' family of proteins. The E4orf4 domains interacting with the various B subunits are overlapping but not identical. Furthermore, interaction with the B' subunits does not contribute to E4orf4-mediated induction of apoptosis.
Results

E4orf4 interacts with both Ba and B' family members
Since several functions of the E4orf4 protein require its interaction with PP2A, we tested whether E4orf4 interacts with dierent PP2A holoenzyme populations. HA-tagged constructs of ®ve cDNAs encoding B' isoforms (McCright et al., 1996) and of the Ba cDNA (Shtrichman et al., 1999) were co-transfected into 293T cells with a plasmid expressing E4orf4 from the immediate early CMV promoter (Shtrichman and Kleinberger, 1998) . Cells transiently transfected with these constructs all expressed the HA-tagged proteins, although to varying levels, and expressed E4orf4 to similar levels ( Figure 1a ). E4orf4 was immunoprecipitated from equal amounts of extract, and the immune complexes were analysed for presence of the various B subunits by staining a Western blot with anti-HA antibodies. Figure 1a demonstrates that all B subunits tested associated with E4orf4 to some extent. The highest level of interaction was manifested by the Ba subunit, which was expressed at relatively low levels, but interacted strongly with E4orf4. B'b and B'a interacted eciently with E4orf4. B'g, which was expressed at least as well as B'a,b, bound E4orf4 less eciently. B'd,e, subunits interacted in proportion to their expression levels. A parallel experiment, in which E4orf4 was omitted from some of the transfections, revealed no interaction of the HA-tagged B subunits with the E4orf4-speci®c antibodies in the absence of E4orf4 (Figure 1b ). An unrelated HA-tagged protein did not co-immunoprecipitate with E4orf4 (data not shown). These results support the conclusion that all B subunits that were examined interacted speci®cally with the E4orf4 protein.
E4orf4 domains participating in the interaction with Ba and B'b are not identical
We next investigated whether B subunits, unrelated by sequence, interacted with dierent domains on the E4orf4 protein. B'b was chosen for this analysis as a representative of the B' subunits since it bound E4orf4 very eciently. We co-transfected plasmids expressing the HA-tagged Ba and B'b subunits with a collection of E4orf4 mutant constructs generated previously (Table  1 and (Shtrichman et al., 1999) ). The various E4orf4 proteins were immunoprecipitated, and the presence of the HA-tagged B subunits in the immune complexes was analysed by Western blots. Figure 2a shows representative Western blots and Figure 2b shows a quantitative summary of three sets of experiments, with the mutants arranged from amino-to carboxyl- The results demonstrate that the binding patterns of the two B subunits to the E4orf4 mutants are not identical. Mutants R4 and R3-9, which bind Ba eciently, bind B'b at reduced levels. Mutant P20 binds both B subunits at reduced levels. Mutant R3-2 binds Ba at reduced levels, but binds B'b more eciently. Interestingly, mutants R3-2 and R3-9 share the same substitution of a.a.s 55 ± 57 to alanines, and mutation R3-2 has an additional substitution of a.a. 78 to arginine. Apparently, the added substitution further alters the conformation of the protein and changes its ability to bind the various B subunits. Thus, whereas mutations in the region between a.a.s 64 (P20) and 78 (R3-2) aect binding to Ba, the region aecting the interaction with B'b includes a.a.s 55 (R3-9) to 75 (R4). These results suggest that the domains required for association of E4orf4 with Ba and B'b partially overlap, but are not identical.
Mutant A3 interacts with PP2A-B subunits, but the complex does not include PP2A-A,C subunits A surprising observation emerged from the set of experiments described in Figure 2 . Both Ba and B'b subunits interacted strongly with mutant A3 (containing a Ser to Pro substitution at position 95). However, in a previous work we showed that the A3 mutant does not co-immunoprecipitate with the PP2A-C subunit, and is not associated with any phosphatase activity towards a phospho-peptide substrate speci®c to PP2A (Shtrichman et al., 1999) . Mutant 44 (containing mutations in a.a.s 19 and 102) also interacted weakly with PP2A-C (Shtrichman et al., 1999) , but showed a We re-examined the interaction of wt E4orf4 and mutant A3 with the various PP2A subunits. 293T cells were transfected with the E4orf4 proteins and the HA-tagged Ba, B'b, or the empty vector. The presence of the various PP2A subunits in the E4orf4 immune complexes was analysed by Western blots. As seen in Figure 3a , both HAtagged Ba and B'b co-immunoprecipitated with the A3 mutant, as did the endogenous Ba subunit. However, the C and A subunits were not present in these complexes, although they were part of the immune complexes containing the wt E4orf4 protein. The wt E4orf4 and mutant A3 proteins were expressed to similar levels in the cells. These results suggest that the altered conformation of the A3 mutant protein does not interfere with its ability to interact with the PP2A-B subunits. However, either the A3 mutant can interact only with free B and B' subunits, or its interaction with PP2A-B,B' results in displacement of the AC core enzyme. We have shown that an interaction with an active PP2A is required for induction of apoptosis by E4orf4, and the A3 mutant does not induce apoptosis (Shtrichman et al., 1999) . Thus, if mutant A3 displaces the core enzyme, it would be expected to act as a dominant negative mutant in apoptosis assays. Figure  3b shows that this is indeed so. Co-transfection with mutant A3 leads to inhibition of apoptosis induced by the wt E4orf4 protein.
Co-localization of E4orf4 and PP2A-B subunits in the cell
Ba and the various isoforms of B' were reported to occupy dierent subcellular compartments. Ba was reported to target PP2A to microtubules (Sontag et al., 1995) , and to vimentin (Turowski et al., 1999) . B'a, b, e were shown to localize to the cytoplasm, whereas B'g was reported to concentrate in the nucleus and B'd was shown to be in the nucleus during mitosis in CV-1 cells (McCright et al., 1996) . In another cell type, B'g1 was reported to target PP2A to focal adhesions (Ito et al., 2000) . To determine whether E4orf4 co-localizes with the various PP2A-B subunits, and whether it aects their normal localization, we performed indirect immuno¯uorescence microscopy. Cells were transfected with the Ba or epitope-tagged B' subunits alone, or in combination with E4orf4, and the transfected proteins were identi®ed by anti-Ba, anti-HA or anti-E4orf4 antibodies. Figure 4 shows that regardless of where the PP2A-B subunits localize in the absence of E4orf4, their staining pattern in the presence of E4orf4 is similar to the E4orf4 staining pattern, and they are localized outside of the nucleus. The staining of E4orf4 in cells co-transfected with B'd,e is somewhat dierent than the staining of cells transfected with B'a,b,g, since the B'd,e-expressing cells seem smaller. However, careful examination of the stained cells revealed that in all co-transfections, the B' subunits were outside the nuclei. Unlike the B subunits, when the green uorescent protein (GFP) was co-transfected with E4orf4, GFP staining patterns were not identical with those of E4orf4, since GFP was found in the nucleus as well as in the cytoplasm.
PP2A-Ba, but not PP2A-B', contributes to induction of apoptosis by E4orf4
We have previously shown that the interaction with an active PP2A containing the Ba subunit is required for induction of apoptosis by E4orf4 (Shtrichman et al., 1999) . We next set out to determine whether PP2A subpopulations containing any of the B' subunits contribute to induction of apoptosis by the viral protein. E4orf4 cDNA was cotransfected into H1299 cells together with an empty vector, or with the Ba or B' subunits, and levels of apoptosis induction were determined by counting DAPI-stained apoptotic nuclei in the transfected cell population. Figure 5a demonstrates that addition of Ba in its native or epitopetagged forms signi®cantly increased the levels of E4orf4-induced apoptosis. However, none of the B' subunits in¯uenced induction of apoptosis by E4orf4. Neither Ba nor the B' subunits induced apoptosis in the absence of E4orf4. These results suggest that an interaction of E4orf4 with a PP2A population containing the Ba subunit, but not the B' subunits, is required (Figure 5c ). These results are consistent with the suggestion that the B' subunit competes with Ba for binding to the AC heterodimer and to E4orf4, but whereas the interaction of E4orf4 with ABaC results in induction of apoptosis, the holoenzyme that includes B' does not mediate E4orf4-induced apoptosis in the cells.
Discussion
Adenovirus E4orf4 protein is a viral regulator that performs several dierent functions, all of which were shown to require an active PP2A. We have previously shown that E4orf4 interacts with a PP2A heterotrimer that contains the Ba regulatory subunit (Kleinberger and Shenk, 1993) . In this report, we show that E4orf4 interacts with members of the B' regulatory subunit family as well. Two lines of evidence support this conclusion. E4orf4 co-immunoprecipitated speci®cally with ®ve epitope-tagged B' isoforms (Figure 1) , and immunohistochemical staining of cells revealed colocalization of E4orf4 and the various epitope-tagged B' subunits co-transfected with it ( Figure 4 ). Control proteins did not immunoprecipitate with E4orf4 (data not shown), and GFP did not co-localize with E4orf4 in the cells as distinctly as did the B' proteins. This data suggests that the interaction of E4orf4 with the B' subunits is speci®c. Utilizing a set of E4orf4 mutants generated previously in our laboratory (Table 1 and (Shtrichman et al., 1999) ), we have further shown that the E4orf4 domains responsible for binding Ba and the B' subunits overlap, but are not identical (Figure 2) . These results are reminiscent of the binding properties of various B subunits to the PP2A-A subunit. A mutation analysis of the A subunit (Ruediger et al., 1999) showed that some mutations in this subunit abolished binding to Ba only or to B' only, while other mutations abolished binding to all B subunits. Thus, the binding sites on the A subunits for the dierent types of B subunits are composed of both distinct and common amino acids. Similarly, the binding sites on E4orf4 for the Ba and B'b subunits contain overlapping and non-overlapping parts. Ba and the B' subunits share little sequence homology, however, it is possible that they share structural components, some of which are required for binding to the A subunit, and others that are needed for the interaction with E4orf4. Since the shared structural components are probably not identical, their interaction with the binding domains on PP2A-A or the E4orf4 vary to some extent.
It is surprising that an eector of PP2A, such as the E4orf4 protein, binds various B subunits. It could be expected that dierent cellular regulators would interact with the dierent subunits, to target them to dierent locations and substrates. Possibly, a multifunctional viral regulator, such as the E4orf4 protein, is not a representative example for cellular regulators, and has been adapted to bind dierent molecules and to perform multiple functions. However, it is also possible that the viral example re¯ects situations in the cell where one eector molecule can bind dierent subpopulations of PP2A. Such situations can include binding PP2A in dierent tissues, which dierentially express the B subunits; binding PP2A populations in E4orf4 interacts with PP2A-B' subunits R Shtrichman et al dierent cellular compartments; or binding various PP2A populations under dierent cellular circumstances, which would favor one interaction or the other. For example, it was demonstrated that many of the B' subunits are phosphorylated (McCright et al., 1996) , and it is possible that dierent phosphorylation states would aect the binding to cellular regulators. The E4orf4 mutant A3 was shown to bind the PP2A-B subunits, but not the A and C subunits (Figure 3a ). This mutant was further shown to be a dominant negative mutant in apoptosis assays ( Figure  3b ). These results suggest that the A3 mutant binds the PP2A holoenzyme, and releases the AC heterodimer. Thus, this mutant can serve as a useful tool in PP2A research, when disruption of the PP2A holoenzyme in vivo is desired.
Since E4orf4 is a multifunctional protein, and its multiple functions all require an active PP2A, it is possible that each function is carried out by an interaction with a dierent subpopulation of PP2A, mediated by binding to the various B subunits. We investigated the contribution of the PP2A populations containing Ba or the B' subunits to E4orf4-induced apoptosis. We have previously shown that Ba contributes to this process, since an antisense construct of Ba abolished E4orf4-induced apoptosis (Shtrichman et al., 1999) . Here, we show that co-transfection of Ba with E4orf4 enhanced the levels of apoptosis induced by E4orf4 alone. However, co-expression of the various B' subunits with E4orf4 did not aect the levels of apoptosis (Figure 5a ). The inability of the B' subunits to aect E4orf4-induced apoptosis did not result from their inability to compete with Ba for binding to E4orf4, since addition of a B' subunit to cells transfected with E4orf4 and Ba led to a signi®cant decrease of apoptosis levels (Figure 5b) . Addition of B' subunits in the presence of endogenous Ba did not decrease apoptosis levels (Figure 5a ), probably because there is excess uncomplexed AC heterodimer in the cells, which can complex with the overexpressed B' subunit (Kremmer et al., 1997) . Only when the pool of AC dimers is exhausted, upon addition of overexpressed Ba, the added B' subunit competes with Ba to form heterotrimers (Figure 5c ), and hence reduces apoptosis. The HA-tagged B' subunits were shown to fully incorporate into the PP2A holoenzyme upon overexpression in cells (McCright et al., 1996) , and we showed (Figure 5c ) that HA-B' subunits compete with Ba for binding to AC. Our results are consistent, therefore, with the conclusion that the B' subunits can bind eciently to the PP2A heterodimer and to E4orf4, but this E4orf4-PP2A complex does not contribute to induction of apoptosis. Thus, distinct interactions of E4orf4 with dierent subpopulations of PP2A have dierent functional consequences. It remains to be seen which of the E4orf4 functions are aected by its interaction with the B' family of PP2A subunits. Our results further suggest the possibility that one set of cellular circumstances that would cause resistance to E4orf4-induced apoptosis may include an increased ratio between B' and Ba subunits in the cell.
Why are B'-containing PP2A molecules unable to mediate E4orf4-induced apoptosis? It is possible that the interaction of E4orf4 with Ba leads to a change in PP2A activity towards an apoptosis-relevant substrate that does not occur in the case of B'. It is also possible that the interaction of E4orf4 with Ba occurs at a unique cellular location that is important to initiation of the apoptotic process, whereas the B' subunits direct PP2A to other cellular locations where the E4orf4 interaction with PP2A does not lead to apoptosis. Another possibility is that E4orf4 brings together PP2A and its apoptosis-relevant substrate, and the ternary complex formation is possible only when Ba is part of the PP2A holoenzyme. Investigation of these possibilities will be possible once the apoptosis-relevant substrates of E4orf4-PP2A are identi®ed.
In conclusion, this report demonstrates for the ®rst time that one eector of PP2A binds dierent subpopulations of the holoenzyme and utilizes them to perform dierent functions. It will be of interest to ®nd whether some cellular regulators of PP2A can act in a similar way.
Materials and methods
Plasmids and cells
The following plasmids have been previously described: pEGFP-C1 (Clontech Lab Inc.), pCMV-E4orf4 or pCMV encoding E4orf4 mutant proteins (Shtrichman and Kleinberger, 1998; Shtrichman et al., 1999) , the pCMV/neo vector (Hinds et al., 1990) , pCMV-PP2A-Ba and the plasmid expressing HA-PP2A-Ba (Shtrichman et al., 1999) , and the plasmids expressing the HA-PP2A-B' subunits (McCright et al., 1996) . PP2A-B'b was subcloned into pcDNA3 (Invitrogen) without the HA tag to create pcDNA3-B'b.
Human 293T cells were derived by introducing the SV40 T antigen into 293 cells. 293 cells are human embryonic kidney cells that express Ad5 E1A and E1B proteins (Graham et al., 1977) . 293T cells and the human non-small-cell lung carcinoma H1299 cells (Mitsudomi et al., 1992) were cultured in Dulbecco's Modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS).
Transfections, immunoprecipitations, and Western blot analysis
Cells were plated in 60 mm culture dishes, and transfections were carried out either by the standard method of calcium phosphate precipitation of DNA (Graham and Van der Eb, 1973) for 293T cells, or with Lipofectamine plus reagent (GibcoBRL) for H1299 cells. Cell extracts were prepared in lysis buer containing 50 mM Tris-HCl (pH 7.4), 250 mM NaCl, 5 mM EDTA, 0.1% Triton X-100, 0.5% Nonidet P-40, 2 mg of leupeptin per ml, 2 mg aprotinin per ml, and 0.5 mM phenylmethylsulfonyl¯uoride. The levels of E4orf4 mutant proteins were analysed by Western blot analysis, using a rabbit polyclonal antibody raised against E4orf4 (Shtrichman and Kleinberger, 1998) . For immunoprecipitations, the antibody was covalently bound to the protein A sepharose (Pharmacia) by dimethyl pymelimidate, as described elsewhere (Harlow and Lane, 1988) . After immunoprecipitation with the anti-E4orf4 beads, the immune complexes were separated on 10% or 15% SDS polyacrylamide gels, and Western blots were stained with antibodies to the PP2A-A, C, Ba subunits or mAb 12CA5, recognizing the HA tag (10% gels) (Shtrichman and Kleinberger, 1998) , and to E4orf4 (15% gels). Immune complexes were detected by chemiluminescence.
Immunofluorescence H1299 cells were transfected in 60 mm plates using lipofectamine plus. After 24 h the cells were ®xed with 4% paraformaldehyde, washed with PBS, ®xed with ice-cold methanol for 30 min, and washed again with PBS. Nonspeci®c sites were blocked with 10% goat serum in PBS ± BT (PBS with 0.5% BSA, 0.05% Tween-20). The cells were then incubated with primary antibodies (mAb 12CA5, or polyclonal anti-E4orf4 antibody) in PBS ± BT and then with secondary (Cy3-conjugated goat anti mouse and FITCconjugated goat anti rabbit; Jackson ImmunoResearch) antibodies at room temperature for 1 h each incubation. After several washes, the cells were stained with 0.1 mg per ml 4,6-diamidino-2-phenylindole dihydrochloride (DAPI, Sigma). A cover slide was mounted on the plates, using Fluoromount-G (Southern Biotechnology Associates, Birmingham, AL, USA). The¯uorescent cells were visualized, using a6600 magni®cation on a Zeiss axioskop.
Apoptosis assays
Cells were plated in 60 mm culture dishes and transfected with 2 mg pEGFP-C1, 1 mg CMV vector expressing wild type E4orf4, and 5 mg plasmid expressing HA-tagged PP2A-B subunit. Thirty hours post transfection, the cells were washed with PBS, ®xed with 4% paraformaldehyde for 15 min, washed again, and stained with 0.1 mg per ml DAPI. A cover slide was mounted on the plates, as described above. Thē uorescent cells were visualized, using a6600 magni®cation on a Zeiss axioskop. The fraction of apoptotic, DAPIstained, nuclei was determined in each experiment by counting 100 transfected nuclei.
